Investing in biotech stocks isn’t for everyone. An unsuccessful clinical trial can cause a huge decline. The competition is usually fierce. Volatility is almost always present.
However, some biotech stocks are exceptions to the rule. And one, in particular, looks like a great pick even for investors who normally would avoid biotech altogether. Here are three reasons why I think Vertex Pharmaceuticals (NASDAQ: VRTX) is the best biotech stock to invest $1,000 in right now.
Sure, Vertex…
Read More…